Zimmer Biomet Holdings P/E Ratio

The latest P/E ratio for ZBH is 26.0. That is above the Healthcare sector average of 22.57. Investors often review this figure alongside Zimmer Biomet Holdings's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, ZBH currently prints 26.0 for P/E ratio, while the sector average sits near 22.57. That is roughly 15.2% above the sector mean. Large gaps often invite a closer look at Zimmer Biomet Holdings's growth, margins, and balance sheet.

A P/E ratio of 26.0 for Zimmer Biomet Holdings is not 'good' or 'bad' on its own. Compare it with the peer average (22.57) and with ZBH's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting ZBH's P/E ratio (26.0), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Zimmer Biomet Holdings's P/E ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.